ARCHIVES

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

This article is from The Cancer Letter archive.

Vol. 26 No. 38 | October 20, 2000

Download PDF Visit The Full Archive

Related Articles

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

Obesity At Prostate-Cancer Diagnosis Increases Risk

March 30, 2007

Pat Barr, Early NBCC Activist, Dead.

June 27, 2003

ASCO Supports Tobacco Tax Increase

March 7, 2003

In Brief: NCI To Move From Westwood, Landow, Blair Bldgs; Kinsella Names UW Oncology Chairman

October 9, 1987